로봇 지원 수술 시스템 시장

The market for robotic-assisted surgery systems is expected to expand from US$ 9.31 billion in 2022 to US$ 25.38 billion by 2031, with a projected CAGR of 14.9% during the period from 2025 to 2031.

Market Insights and Analyst View:The robotic-assisted surgery systems market includes a variety of advanced surgical platforms that combine robotics, imaging, and navigation technologies to aid surgeons in conducting minimally invasive procedures with enhanced precision and control. These systems aim to improve surgical capabilities, enhance patient outcomes, and reduce the invasiveness associated with traditional surgical methods. Key advantages of robotic-assisted surgery systems include improved dexterity, three-dimensional visualization, and tremor suppression, enabling surgeons to execute complex procedures with greater accuracy and flexibility. These systems often facilitate access to challenging anatomical regions, resulting in less trauma and quicker recovery times for patients. Furthermore, the incorporation of robotics in surgical procedures reduces the likelihood of complications and decreases the need for blood transfusions, ultimately leading to better post-operative results.

Growth Drivers and Challenges:The rising number of research initiatives investigating the advantages and functionalities of robot-assisted surgeries is expected to drive market growth in the upcoming years. In September 2022, researchers from the Graduate School of Medical Sciences at Nagoya City University (NCU) conducted a study comparing robotic-assisted, fluoroscopic-guided, and ultrasound-guided renal access for percutaneous nephrolithotomy. The results indicated the safety and user-friendliness of innovative robotic devices, which could alleviate the training demands on surgeons and enable more hospitals to perform PCNL procedures. This approach, utilizing AI-driven robotics, may pave the way for the automation of similar surgical interventions, thereby expediting processes and reducing complication risks.

The increase in chronic disease prevalence and the rising preference for minimally invasive surgeries further support the growth of the robotic-assisted surgical systems market. According to a report by The Hindu in August 2022, Apollo Health City in Hyderabad, India, has successfully completed over 500 robot-assisted gynecological surgeries. In November 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, and Venkateshwar Hospital in Delhi announced the completion of the first urological procedure in northern India using the Hugo robotic-assisted surgery (RAS) system.

Conversely, the high costs associated with robotic surgical systems pose challenges to the financial feasibility and operational sustainability of healthcare providers. While these systems provide benefits such as enhanced precision, reduced invasiveness, and shorter recovery times, the significant initial investment and ongoing maintenance expenses require careful financial planning and resource allocation for healthcare facilities. Additionally, the necessity for specialized training and certification for surgical staff to operate these systems adds to operational costs, affecting the overall affordability and practicality of incorporating robotic surgery into existing clinical practices. The financial burden linked to robotic surgical systems may influence healthcare reimbursement models and coverage decisions, as reimbursement rates for procedures performed with robotic assistance can vary, impacting the economic justification for adopting these technologies. This creates a complex scenario where healthcare facilities must balance the clinical benefits of robotic surgery against the financial implications, potentially affecting the rate and extent of adoption across various healthcare systems.

Strategic Insights

Report Segmentation and Scope:The robotic-assisted surgery systems market is categorized based on product type, application, and end user. In terms of product type, the market is divided into systems, instruments and accessories, and services. By application, the market is segmented into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. Based on end user, the market is classified into hospitals, ambulatory surgery centers, and other end users. Geographically, the robotic-assisted surgery systems market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and the rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the rest of South & Central America).

Segmental Analysis:In terms of product type, the surgical robot segment accounted for a significant revenue share of the robotic-assisted surgery systems market in 2022. The demand for surgical robots to conduct precise and accurate procedures is expected to rise due to the increasing global incidence of cardiovascular and cancer-related disorders. The American Cancer Society's Cancer Statistics 2023 predicts that the US will report 1.9 million new cancer cases in 2023. According to the Australian Institute of Health and Welfare's (AIHW) 2021 report, there were an estimated 150,800 new cancer cases in Australia in 2021. The Australian Bureau of Statistics reported in March 2022 that approximately 4.0% of Australians, or 1.0 million people, were estimated to have heart disease in 2021.

By application, the robot-assisted surgical systems market is categorized into gynecological surgery, cardiovascular, neurosurgery, orthopedic surgery, laparoscopy, urology, general surgery, and others. The neurology sector is anticipated to experience the fastest CAGR from 2022 to 2030. The increasing adoption of surgical robots in general surgeries and the advantages they provide over traditional surgical methods are beneficial to the overall market. Additionally, advancements in technology and successful outcomes in robotic neurosurgery are expected to drive the growth of the robotic-assisted surgical systems market in the coming years. According to SS Innovations Interventional Inc., around 1.6 million robotic surgeries were performed globally in 2020.

By end user, the robot-assisted surgical systems market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospital segment led the market in 2022 and is projected to register a high CAGR from 2022 to 2030. The growth of the hospital segment is attributed to rising healthcare costs across various economies. Hospitals provide high-quality care by utilizing the latest robotic-assisted surgical technologies. Moreover, physicians and surgeons favor robot-assisted systems. The proportion of robot-assisted surgeries in total surgical procedures increased significantly from 1.8% in 2013 to 15.1% in 2019, as reported in a paper published in the JAMA network.

Regional Analysis:Geographically, the robotic-assisted surgery systems market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of this market. The market growth in this region is driven by the increasing use of automated surgical instruments and the adoption of next-generation healthcare systems in the US. Additionally, the shortage of surgeons and medical professionals in the US relative to the patient population is expected to benefit the market for robotic-assisted surgical systems. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions is driving demand for robotic-assisted surgical systems in the US.

The growing preference for minimally invasive procedures over traditional surgeries supports the robotic-assisted surgery systems market. In December 2022, Hugo expanded its clinical trials for its robotic-assisted surgery (RAS) systems in the US by enrolling their first patient, according to Medtronic plc. Furthermore, in 2022, a physician at Duke University Hospital in Durham, North Carolina, performed a robotic-assisted prostatectomy.

The Asia Pacific robotic-assisted surgical systems market is projected to grow at the fastest CAGR from 2022 to 2030, driven by the increasing patient population and the rising adoption of advanced automated surgical instruments. Additionally, the expansion of modern healthcare facilities and growing public awareness of the benefits of advanced medical technologies are expected to support market growth in this region in the future. Governments in Asia Pacific countries are making efforts to develop sophisticated healthcare infrastructure, attracting international companies to invest in the establishment of automated instrument development facilities in the region. China holds the largest share of the robotic-assisted surgical systems market in Asia Pacific, while India is expected to achieve the highest CAGR from 2022 to 2030. Companies in the surgical robotics sector in China have expedited their time to market by utilizing a special approval pathway that accelerates regulatory approval for innovative medical products. Moreover, a growing number of medtech firms specializing in surgical robotics are emerging in the country. Recently, JianJia Robots and Hurwa entered the Chinese market to develop surgical robotics solutions alongside TINAVI, a domestic company focused on orthopedic surgical robots. Beijing provides reimbursement for TINAVI robot-assisted surgeries for spinal, hip, and knee procedures.

Robotic Assisted Surgery Systems Market Report Scope

Industry Developments and Future Opportunities:Key initiatives undertaken by major players in the global robotic-assisted surgery systems market include:

In October 2023, Johnson & Johnson MedTech, a division of DePuy Synthes, launched the VELYS Robotic Assisted Solution, which has been utilized in total knee replacement surgeries in Germany, Belgium, and Switzerland. This launch expands DePuy Synthes' networked technologies within its Digital Surgery Platform to address unmet needs for orthopedic robots.

In November 2022, an Indian Medtech company partnered with Avra Medical Robotics, an American Nasdaq-listed firm. SS Innovations introduced the SSI Mantra, the first surgical robot entirely "Made in India," which is a highly advanced surgical robotic system with more features and applications than other systems available.

In November 2022, the FDA in the United States approved an update to Accelus's software for the Remi Robotic Navigation System, enabling surgeons performing lumbar spine fixation to place pedicle screws with robotic assistance. Accelus is a private medical technology company focused on promoting minimally invasive surgery (MIS) as the standard of care in spine procedures.

Competitive Landscape and Key Companies:Prominent players in the robotic-assisted surgery systems market include Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc., SRI International Inc., Accuray Incorporated, Renishaw PLC, Medtronic PLC, Brainlab, Smith & Nephew PLC, Globus Medical, and Zimmer Biomet. These companies are focused on expanding their product offerings to meet the increasing global demand. Their international presence enables them to serve a broad customer base, thereby allowing them to enhance their market share.

Table Of Contents

1. Introduction

• 1.1 Scope of the Study
• 1.2 Market Definition, Assumptions and Limitations
• 1.3 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Robotic Assisted Surgery Systems Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis
• 4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Robotic Assisted Surgery Systems Market - Key Market Dynamics

• 5.1 Key Market Drivers
• 5.2 Key Market Restraints
• 5.3 Key Market Opportunities
• 5.4 Future Trends
• 5.5 Impact Analysis of Drivers and Restraints

6. Robotic Assisted Surgery Systems Market - Global Market Analysis

• 6.1 Robotic Assisted Surgery Systems - Global Market Overview
• 6.2 Robotic Assisted Surgery Systems - Global Market and Forecast to 2030

7. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Product Type, 2020-2030

• 7.1 Overview
• 7.2 System
• 7.3 Consumable and Accessories
• 7.4 Software and Services

8. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By Application, 2020-2030

• 8.1 Overview
• 8.2 Gynecological Surgery
• 8.3 Cardiovascular
• 8.4 Neurosurgery
• 8.5 Orthopedic Surgery
• 8.6 Laparoscopy
• 8.7 Urology
• 8.8 Other Applications

9. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million) - By End User, 2020-2030

• 9.1 Overview
• 9.2 Hospitals
• 9.3 Ambulatory Surgery Centers
• 9.4 Other End Users

10. Robotic Assisted Surgery Systems Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

• 10.1 North America
  • 10.1.1 North America Robotic Assisted Surgery Systems Market Overview
  • 10.1.2 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts to 2030
  • 10.1.3 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Product Type
  • 10.1.4 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Application
  • 10.1.5 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By End User
  • 10.1.6 North America Robotic Assisted Surgery Systems Market Revenue and Forecasts and Analysis - By Countries
    • 10.1.6.1 United States Robotic Assisted Surgery Systems Market
      • 10.1.6.1.1 United States Robotic Assisted Surgery Systems Market, by Product Type
      • 10.1.6.1.2 United States Robotic Assisted Surgery Systems Market, by Application
      • 10.1.6.1.3 United States Robotic Assisted Surgery Systems Market, by End User
    • 10.1.6.2 Canada Robotic Assisted Surgery Systems Market
      • 10.1.6.2.1 Canada Robotic Assisted Surgery Systems Market, by Product Type
      • 10.1.6.2.2 Canada Robotic Assisted Surgery Systems Market, by Application
      • 10.1.6.2.3 Canada Robotic Assisted Surgery Systems Market, by End User
    • 10.1.6.3 Mexico Robotic Assisted Surgery Systems Market
      • 10.1.6.3.1 Mexico Robotic Assisted Surgery Systems Market, by Product Type
      • 10.1.6.3.2 Mexico Robotic Assisted Surgery Systems Market, by Application
      • 10.1.6.3.3 Mexico Robotic Assisted Surgery Systems Market, by End User
• 10.2 Europe
  • 10.2.1 Germany
  • 10.2.2 France
  • 10.2.3 Italy
  • 10.2.4 Spain
  • 10.2.5 United Kingdom
  • 10.2.6 Rest of Europe
• 10.3 Asia-Pacific
  • 10.3.1 Australia
  • 10.3.2 China
  • 10.3.3 India
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 Rest of Asia-Pacific
• 10.4 Middle East and Africa
  • 10.4.1 South Africa
  • 10.4.2 Saudi Arabia
  • 10.4.3 U.A.E
  • 10.4.4 Rest of Middle East and Africa
• 10.5 South and Central America
  • 10.5.1 Brazil
  • 10.5.2 Argentina
  • 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

• 12.1 Mergers and Acquisitions
• 12.2 Agreements, Collaborations, Joint Ventures
• 12.3 New Product Launches
• 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

• 13.1 Heat Map Analysis by Key Players
• 13.2 Company Positioning and Concentration

14. Robotic Assisted Surgery Systems Market - Key Company Profiles

• 14.1 Intuitive Surgical Inc.
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
• 14.2 Stryker Corporation
• 14.3 Johnson and Johnson Inc.
• 14.4 SRI International Inc.
• 14.5 Accuray Incorporated
• 14.6 Renishaw PLC
• 14.7 Medtronic PLC
• 14.8 Smith and Nephew PLC
• 14.9 Brainlab
• 14.10 Globus Medical

15. Appendix

• 15.1 Glossary
• 15.2 About The Insight Partners
• 15.3 Market Intelligence Cloud